Læknablaðið - 01.04.1978, Síða 67

LÆKNABLAÐIÐ
81
28. Garcia, M.J. et al.: Morbidity and mortality
in diabetics in the Framineham population.
Sixteen year followup study. Diabetes, 23, 105.
1974.
29. Geer, J.C. & Haust, M.D. „Smooth muscle
cells in atherosclerosis“, Monojrraphs on
Atherosclerosis, Vol. 2 [Kargrer], Basel 1972.
30. Glomset, J.A. & Verdery, R.B. Role of LCAT
in cholesterol metabolism. 1 Cholester Metabol-
ism and Lipolytic Enzymes, 137-142 (ed.
I’olonovsky, J.] [Marson Publishinp] N.Y.
1977.
31. Goldstein, J. et. al.: Hyperlipidemia in coron-
ary heart disease. J. Clin. Invest. 52, 1533.
1973.
32. Goodkin, G. Mortality factors in diabetes. J.
Occup. Med. 17, 716. 1975.
33. Gordon, T. & Kannei, W.B. Obesity and cardio-
vascular disease: the Framingham Study.
Clinics in Endocrinology and Metabolism, 5,
367. 1976.
34. Gordon, T. et al.: Death and coronary attacks
in men after privinp up ciparette smoking.
Lancet 1345. 1974.
35. Gunnar Sigurðsson. Hækkuð blóðfita. Lækna-
blaðið, 1, 37. 1974.
36. Gunnar Sigur(fsson, Mataræði, kóiesteról og
kransæðasjúkdómar. Hjartavernd, 14, 2, (4-7).
1977.
37. Gunnar Sigurðsson et al.: Islenzkt mataræði.
Læknablaðið, 62, 87. 1976.
38. Hammond, E.C. & Garfinkel, L. Coronary
heart disease, stroke and aortic aneurysm.
Factors in the etiology. Arch. Environ. Health
(Chicago) 19:167. 1969.
39. Haust, M.D., Atherosclerosis in Concepts of
Disease (ed. E. Gali & J. Brunsen) [Mac-
Millan] London. 1970.
40. Heilbrigðisskýrslur. 1973.
41 Holme, J. et al.: Coronary risk factors and
socioeconomic status. The Oslo study. Lancet
1396. 1976. .
42. Hóprannsókn Hjartaverndar, 1. afangi. O-
birtar niðurstöður.
43. Ischaemic heart disease: A secondary Pre"
vention trial using ciofibrate. Report by a
research committee of the Scottish Society of
Physicians. Brit. Med. .1. 4, 775. 1971.
44. Jarrett. R.J. & Keen, H Epidemiology of dia-
betes í Diabetes Meliit.us. 4th ed. (Sussman.
K.E. & Metz. R.J.S. eds.) [Amer. Diabetes
Assoc. Inc.] N.Y. 1975.
45. Jarret, R.J. & Keen, H. Hyperglycemia and
diabetes mellitus, Lancet 1009. 1976.
46. Jarrett, R.J. et al.: Treatment of borderline
diabetes: controHed trial using carbohydrate
restriction and p-henformin. Brit. Med. J. 2.
861. 1977.
47. Jenkins. C.D. Recent evidence supportmg
nsychologic and social risk factors for coron-
arv heart disease. New Engi. J. Med. 294,
987-994, 1033-1038. 1976.
48. Kahn. H.A. The Dorn Study of smoking and
mortality among U.S. veterans. Report on 8%
years of observation. Enidemiologicai Appro-
aches to the Study of Cancer and other Dis-
eases. (ed. Haenszel. W.) National Cancer
Jnstitute Monograph No. 19 1-125. [Public
Health Service] Bet.hesda. Maryland, U.S.
1976.
49. Kannel, W.B. Coronary risk factors: Recent
highlights from the Framingham St.udy.
Australian .T. Med. 6, 373-386. 1976.
50. Kannel. W.B. Role of blood pressure in
cardiovascular morbidity and mortality. Pro-
gress in Cardiovascular Diseases, 17, 5-24.
1974.
51. Kannel, W.B. et al.: Serum cholesterol, lipo-
proteins and the risk of coronary heart dis-
ease: The Framingham Study. Ann. Intern.
Med. 74:1. 1971.
52. Kannel, W.B. & Dawber, T.R. Hypertension
as an ingredient of a eardiovascular risk
profile. Brit. J. Hosp. Med., 508-523. 1974.
53. Kannel, W.B. et al.: A general cardiovascuiar
risk profile; The Framingham Study. Amer.
J. Cardiol. 38, 46-51. 1976.
54. Kannei, W.B. et ab: The relation of physical
activity to risk of coronary disease. The
Framingham Study. í Coronary Heart Dis-
ease and Physicai Fit.ness. (Larson, O.A. &
Malmborg, R.O. eds.) [Munksgard] Copen-
hagen. 1971.
55. Katz, S.S. et al.: Physical Chemistry of the
Lipids of Human Atherosclerotic Lesions;
Demonstration of a lesion intermediate bet-
ween fatty streaks and advanced plaques. J.
Clin. Invest. 58:200-211. 1976.
56. Keen, H. & Jarrett, J. (eds.) Complications
of Diabetes. [Edward Arnold] England. 1976.
57. Keys, A. (Editor). Coronary heart disease in
seven countries. Circulation 41 (Suppl. 1):
I. 1970.
58. Keys, A. Coronary heart disease — the
global pict.ure. Atherosclerosis 22, 149. 1975.
59. Keys, A. ct al.: Epidemiological studies re-
lated to coronary heart disease: Characteris-
tics of men aged 40-59 in seven countries. Acta
Med. Scand. (suppl.):460. 1966.
60. Keys, A. et al.: The probability of middle-
aged men developing coronary heart disease
in five years. Circulation, 45, 815. 1972.
61. Koiata, G.B. Atherosclerotic plaques. compet-
ing theories guide research. Science 194. 592-
594. 1977. „ ,.
62. Köpperiing. J. et al.: Follow-up of „non-dia-
betic“ relatives of diabetics by retesting oral
glucose tolerance after 5-years. Diabetologia
II. 451. 1975.
63. Lewis, B. et al.: Serum lipoprotein abnormal-
ities in patients with ischaemic heart disease:
Comparisons wit.h a control population. Brit.
Med. J. 489. 1974.
64. McGill, H.D. (ed.) Geographic PatholoBy of
Atherosclerosis. [Williams & Wilkins] Bali-
more. Maryland. 1968.
65 Miettinen, M. et al.: Effect of cholesterol-
lowering diet on mortality from coronary
heart disease and other causes. Lancet, ii, 835.
1972. , . ,
36. Miller, G.J. & Miiler, N.E. Plasma high-
density-lipoprotein concentration and develop-
ment of ischaemic heart disease. Lancet, i,
16. 1975.
67. Morris, J.N. et al.: Vigorous exercise ín
leisure-time and t.he incidence of coronary
heart disease. Lancet 333. 1975.
68. Mulcahy, R. et ab: Factors influencing long-
term prognosis in male patients surviving a
first coronary attack. Brit. Heart. J. 37, 158.
1975
69 Paasikivi, J. Longtcrm tolbutamide treatment
after myocardial infarction. Acta med. scand.
suppl. 507. 1970.
70 Pearson. D. Intravenous glucose to'erance ín
myocardiai infarction. Postgrad. Med. J. 47.
648 1971
71 Pelkonen. R. et. al.: Association of serum
Hnids and obesitv with cardivascular morta-
lity. Brit. Med. J. 2, 1185. 1977.